Valuation: BioGaia AB

Market Cap 12.71B 1.27B 1.15B 1.06B 958M 1.81B 119B 1.86B 5.05B 63.74B 4.76B 4.66B 203B P/E 2026 *
31.4x
P/E 2027 * 25.9x
Enterprise Value 12.03B 1.2B 1.09B 1B 907M 1.71B 113B 1.76B 4.78B 60.35B 4.51B 4.41B 192B EV / Sales 2026 *
7.13x
EV / Sales 2027 * 6.25x
Free-Float
80.82%
Yield 2026 *
3.26%
Yield 2027 * 2.96%
1 day-0.16%
1 week+3.04%
Current month+4.32%
1 month+7.53%
3 months+11.94%
6 months-3.38%
Current year+18.27%
1 week 118.8
Extreme 118.8
127.4
1 month 117.5
Extreme 117.5
135
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 54
Extreme 54
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Director/Board Member 46 01/01/2015
Director/Board Member 40 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/10/26 Sell

Director

-20,000 0.0203%
26/10/26 Sell

Director

-10,000 0.0102%
26/10/26 Sell

Director

-10,000 0.0102%
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%+3.04%+22.54%+20.19% 1.28B
-0.70%+4.58%+40.23%+138.79% 1,280B
+1.11%+4.11%+45.85%+92.54% 675B
-0.18%+2.15%+26.25%+112.46% 521B
+1.14%+2.68%+40.80%+71.70% 386B
-0.16%+0.01%+60.69%+44.94% 363B
+1.11%-0.03%+28.96%+60.05% 301B
+0.24%-0.67%+3.45%+38.06% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 211B
Average +0.11%+0.15%+34.38%+77.47% 428B
Weighted average by Cap. +0.06%+0.35%+37.66%+97.30%

Financials

2026 *2027 *
Net sales 1.69B 168M 152M 141M 127M 240M 15.83B 247M 671M 8.46B 632M 619M 26.94B 1.92B 192M 173M 160M 145M 273M 18.01B 281M 763M 9.63B 719M 704M 30.65B
Net income 408M 40.77M 36.87M 34.03M 30.8M 58.13M 3.83B 59.87M 162M 2.05B 153M 150M 6.52B 490M 48.88M 44.2M 40.8M 36.93M 69.69M 4.6B 71.78M 195M 2.46B 183M 180M 7.82B
Net Debt -675M -67.33M -60.89M -56.2M -50.87M -96M -6.33B -98.88M -268M -3.38B -253M -247M -10.77B -716M -71.42M -64.58M -59.61M -53.96M -102M -6.71B -105M -284M -3.59B -268M -262M -11.42B
Projected Income Statement - Annual - BioGaia AB
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
12/11/26 SEK 125.60 -0.16% 169,635
11/11/26 SEK 125.80 +2.03% 116,679
10/11/26 SEK 123.30 -0.80% 145,804
09/11/26 SEK 124.30 +1.80% 187,954
06/11/26 SEK 122.10 +1.24% 85,952
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - BioGaia AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
125.60SEK
Average target price
152.00SEK
Spread / Average Target
+21.02%
  1. Stock Market
  2. Stocks
  3. BIOG B Stock